355 related articles for article (PubMed ID: 26141719)
1. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C
BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719
[TBL] [Abstract][Full Text] [Related]
2. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
3. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
4. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
6. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer.
Frick EA; Kristjansdottir K; Ragnarsdottir S; Vilhjalmsson AI; Bustos MR; Vidarsdottir L; Gudjonsson T; Sigurdsson S
Breast Cancer (Auckl); 2024; 18():11782234241234771. PubMed ID: 38504674
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
Cochrane DR; Cittelly DM; Howe EN; Spoelstra NS; McKinsey EL; LaPara K; Elias A; Yee D; Richer JK
Horm Cancer; 2010 Dec; 1(6):306-19. PubMed ID: 21761362
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
12. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
Di Leva G; Gasparini P; Piovan C; Ngankeu A; Garofalo M; Taccioli C; Iorio MV; Li M; Volinia S; Alder H; Nakamura T; Nuovo G; Liu Y; Nephew KP; Croce CM
J Natl Cancer Inst; 2010 May; 102(10):706-21. PubMed ID: 20388878
[TBL] [Abstract][Full Text] [Related]
14. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.
Castellano L; Giamas G; Jacob J; Coombes RC; Lucchesi W; Thiruchelvam P; Barton G; Jiao LR; Wait R; Waxman J; Hannon GJ; Stebbing J
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15732-7. PubMed ID: 19706389
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
16. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
Majed SO; Mustafa SA
BMC Cancer; 2021 Apr; 21(1):473. PubMed ID: 33910530
[TBL] [Abstract][Full Text] [Related]
17. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.
Kim YS; Park SJ; Lee YS; Kong HK; Park JH
Oncotarget; 2016 Jul; 7(27):42261-42273. PubMed ID: 27304060
[TBL] [Abstract][Full Text] [Related]
18. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
19. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H
Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897
[TBL] [Abstract][Full Text] [Related]
20. CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer.
Frick E; Gudjonsson T; Eyfjord J; Jonasson J; Tryggvadóttir L; Stefansson O; Sigurdsson S
Oncotarget; 2019 Jul; 10(45):4664-4678. PubMed ID: 31384394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]